It is the time of the year when companies more and more companies are providing updates to shareholders for the New Year and yesterday, it was the turn of Sirona Biochem Corp (OTCMKTS:SRBCF). The update provided by the company proved to be a significant boost for the Sirona stock and it ended up with gains of as much as 4% for the day.
Trading Data
On Wednesday, SRBCF stock ended moved up 3.95% to $0.1601 with 30k shares, compared to its average volume of 44k shares. The stock has moved within a range of $0.1599 – 0.1650 after opening trade at $0.1650.
Sirona Biochem CEO Quarterly Update
In this situation, it is the right time for investors to take a look at some of the highlights provided by the company in the letter. In the letter, the shareholders were informed that Sirona is look into a range of value added measures that will help in bringing in considerable growth in 2022.
On the other hand, the company also thanked the shareholders for the continued support. However, in this regard, it is also necessary to mention that Sirona also noted that it was currently negotiating with a major pharmaceutical company for granting the rights related to TFC 1067. The pharmaceutical company is among the top 10 pharmaceutical companies in the world. In light of that fact, it may be a good time for investors to add the stock to their watch lists.
Technical Data
SRBCF stock is trading above the 20-Day and 50-Day Moving averages of $0.1546 and $0.1596 respectively. However, the stock is trading below the 1000-Day moving average of $0.1981.
